At present, it cannot be excluded that the elevated FASN+ EVs in glioma patients could also in part stem from other cell types in the tumor microenvironment, such as macrophages/microglia which possibly also exit the brain through a disrupted blood-brain barrier to enter the bloodstream. This evidence concerns the gene FASN and central nervous system cancer.